Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19
SARCO-V
1 other identifier
observational
46
1 country
1
Brief Summary
The SarcoV study aims at assessing the association between sarcopenia and the indication of mechanical ventilation in older hospitalized patients due to COVID-19 infection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 23, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2021
CompletedApril 6, 2022
March 1, 2022
12 months
February 23, 2021
March 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Indication of mechanical ventilation
Association between probable sarcopenia and the indication of mechanical ventilation in patients with COVID-19 infection. Mechanical ventilation was considered by non-invasive ventilation or invasive ventilation. For purpose of analysis, it was defined as a binary outcome (yes(no). Probable sarcopenia probable was defined according to the revised European consensus on definition and diagnosis of sarcopenia (EWGSOP2). For purpose of analysis, it was defined as a binary condition (yes/no).
Through study completion, an average of 60 days
Secondary Outcomes (2)
Evaluate difficult-to-wean in mechanical ventilation
Through study completion, an average of 60 days
All-cause mortality
Through study completion, an average of 60 days
Eligibility Criteria
Patients aged 60 and older admitted in an acute care unit of Brugmann university hospital due to COVID-19
You may qualify if:
- Consecutive patients aged 60 and older
- Admission in an acute care unit in Brugmann university hospital due to a COVID-19 possible or confirmed infection. A infection was considered confirmed in presence of a positive molecular test by Polymerase-chain reaction (PCR), following the Belgian Public Health Department recommendations (Sciensano recommendations).
You may not qualify if:
- Patients unable to perform a grip-strength measurement due to any rheumatological or neurological condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brugmann university hospital
Brussels, 1020, Belgium
Related Publications (2)
Kou HW, Yeh CH, Tsai HI, Hsu CC, Hsieh YC, Chen WT, Cheng HT, Yu MC, Lee CW. Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients. PLoS One. 2019 Aug 8;14(8):e0220699. doi: 10.1371/journal.pone.0220699. eCollection 2019.
PMID: 31393937BACKGROUNDCruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046. No abstract available.
PMID: 31081853BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Dr Murielle Surquin MD PhD
Study Record Dates
First Submitted
February 23, 2021
First Posted
February 26, 2021
Study Start
September 1, 2020
Primary Completion
August 20, 2021
Study Completion
August 20, 2021
Last Updated
April 6, 2022
Record last verified: 2022-03